Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 294

The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.

Assessing the Role of Circulating, Genetic, and Imaging Biomarkers in Cardiovascular Risk Prediction

Open access
Wang, Thomas J. · 2011 · Circulation

Abstract

Never make forecasts. Especially about the future. —Samuel Goldwyn The use of biomarkers to augment traditional cardiovascular risk prediction has attracted considerable attention in the past decade. This interest has been fueled by the realization that traditional risk factors do not identify everyone who will eventually develop cardiovascular disease.1 This has been accompanied by the emergence of potential screening tests such as high-sensitivity C-reactive protein (CRP), single-nucleotide polymorphism arrays, and coronary calcium scanning. Nonetheless, whether these biomarkers are ready for routine clinical use, to be measured alongside existing tests such as cholesterol, is controversial. Recently, the US Preventive Services Task Force concluded that “current evidence is insufficient to assess the balance of benefits and harms of using the nontraditional risk factors.”2 This conclusion underscores gaps in the current literature, as well as the inherent challenge of predicting the occurrence of future cardiovascular events in generally healthy adults. However, the use of newer screening tests for cardiovascular risk assessment has been endorsed in some quarters. For instance, the state of Texas passed legislation in 2009 mandating the coverage of screening coronary calcium scans in older adults. Furthermore, the Food and Drug Administration recently expanded the labeling of a statin drug, rosuvastatin, to include older individuals with elevated CRP levels in addition to conventional risk factors. The present article reviews the case for and against the use of newer biomarkers for cardiovascular risk prediction. There are literally hundreds of circulating, genetic, and imaging biomarkers that have been proposed or evaluated in the cardiovascular literature. Several comprehensive reviews exist on the topic.3,4 Rather than attempting to provide a systematic overview, this article focuses on a few of the most illustrative biomarkers. Particular emphasis will be given to placing these biomarkers in a pathophysiological context (what stage of disease …

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.109.912568

Cites

128 of 128 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 128 references

Cited by

See all 294

Metadata

Authors
Wang, T. J.
Venue
Circulation
Published
2011-02-08
Volume
123
Issue
5
Pages
551-565
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2048530377
Cited by
294
References
128
FWCI
26.52
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Assessing the Role of Circulating, Genetic, and Imaging Biomarkers in Cardiovascular Risk Prediction. https://app.cochat.ai/papers/10.1161/circulationaha.109.912568
The paper
Wang, T. J. (2011). Assessing the Role of Circulating, Genetic, and Imaging Biomarkers in Cardiovascular Risk Prediction. Circulation. https://doi.org/10.1161/circulationaha.109.912568

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.